New pill could keep lung cancer away after surgery
Disease control
Recruiting now
This study tests a daily pill called sunvozertinib against a placebo in 360 people with a specific type of lung cancer (stage IB-IIIA) who have had surgery to remove their tumor. The goal is to see if the drug can stop the cancer from returning. Participants must have certain EGF…
Phase 3 • Sponsor: Dizal (Jiangsu) Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC